Sheba Pediatric CAR-T Program for Leukemia (ALL & CLL) at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek
O que está incluído neste pacote
Procedimentos médicos
- Hemograma completo
- Análise bioquímica do sangue
- Consulta com hematologista
- Análise alargada de sangue
- Consulta com um onco-hematologista
- Diagnóstico abrangente de leucemia
- Terapia com células T CAR
- 3 refeições por dia pelo nutricionista
- Serviços de enfermagem 24 horas
- Radiografia do tórax
- Teste anti-HIV
- Teste anti-HBC
- Teste Anti-HCVAb
- Ecocardiografia
- Consulta com um oncologista
- Consulta com um hematologista
- Consulta com um imunologista
- Consulta com um hematologista pediátrico
- Consulta com um pediatra
- Ressonância Magnética do Crânio
- Ecocardiografia Doppler colorido
- Hemograma completo com marcadores tumorais e proteinograma
Duração
- 21 dias no hospital
Acomodação
Hospitalização
Transporte
Transfer aeroporto-hotel-aeroporto
Informações adicionais
Sheba Pediatric CAR-T Program for Leukemia (ALL & CLL)
At Sheba Medical Center, children and young patients with leukemia have access to one of the most advanced and trusted CAR-T therapy programs in the world. The program specializes in treating acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) including relapsed or treatment-resistant cases using highly personalized immunotherapy.
A Personalized Treatment Designed for Each Patient
CAR-T therapy uses the patient’s own immune system to recognize and destroy leukemia cells. This approach is especially important for patients who have not responded to standard treatments.
At Sheba, the entire process is performed on-site, ensuring speed and optimal quality:
Apheresis – collection of immune (T) cells
Cell Engineering – genetic modification at Sheba’s Advanced Biotherapy Center
Infusion – reintroduction of modified cells to target leukemia
Because no steps are outsourced, treatment can begin quickly and is typically completed within ~10 days. CAR-T acts as a “living therapy,” continuing to work in the body over time.
Expert Care in a Supportive Environment
Patients are treated by leading hemato-oncology specialists, under the supervision of Prof. Amos Toren, within dedicated CAR-T units.
The program provides:
Specialized pediatric and young adult CAR-T care with 24/7 monitoring
A multidisciplinary team (hematology, oncology, immunology)
A supportive, patient- and family-centered environment
Full international patient services, including travel and care coordination
Proven Outcomes and Global Leadership
Sheba is a global leader in CAR-T therapy, with strong clinical outcomes:
~90% remission in pediatric patients
~80% in young adults (up to 23 years)
~70% in adults
The program is experienced in treating complex and high-risk leukemia cases, offering options when other treatments are limited.
Comprehensive Evaluation and Ongoing Support
Each patient undergoes a full diagnostic work-up, including:
advanced imaging, bone marrow biopsy, genetic and molecular testing, as well as cardiac and pulmonary evaluation.
Care is provided in English, Russian, and Arabic, ensuring clear communication and continuous support for international families.
A Place Patients and Families Can Trust
By combining advanced science, rapid access to treatment, and compassionate care, Sheba offers one of the most trusted CAR-T programs for leukemia—focused on achieving remission and helping patients return to a healthy, active life.
Assistência Bookimed 24/7
- Coordenador médico pessoal
- Arranjos de viagem médica — reserva de passagens aéreas e quartos de hotel com preços especiais de parceiros
- Defesa do paciente durante a viagem médica
Preço do programa
O que NÃO está incluído neste pacote
Médico
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Como estamos indo?
Sobre a clínica
O Hospital Chaim Sheba (Tel Hashomer) — é uma das maiores clínicas públicas de Israel. Ela é composta por 150 centros e departamentos. A clínica se especializa em oncologia, onco-hematologia, neurocirurgia, pediatria e reabilitação.
Mais de 1.000 médicos trabalham aqui. Sheba recebe anualmente 1 milhão de pacientes. A clínica colabora com o centro oncológico MD Anderson (EUA) e recebeu a acreditação JCI (Joint Commission International) — Comissão Internacional de Qualidade em Serviços de Saúde.
Pagamento e Recompensas
Não pague por nossos serviços
Efetue o pagamento diretamente na clínica ou na conta bancária oficial dela.
Algumas clínicas podem exigir um depósito como parte de sua política.
Divida seus pagamentos com opções de parcelamento.
Ganhe recompensas por indicar amigos ao Bookimed.